Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity

Immunity

Volumn 19, Issue 5, 2003, Pages 679-688

  Wildbaum, Gizi ^a   Nahir, Menahem A ^a,b   Karin, Nathan ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIBODY; DNA VACCINE; EPITOPE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; GENE AMPLIFICATION; IMMUNE DEFICIENCY; IMMUNITY; INFLAMMATION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0345358581     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00291-7     Document Type: Article

References (41)

1. Arend W.P., Malyak M., Smith M.F. Jr., Whisenand T.D., Slack J.L., Sims J.E., Giri J.G., Dower S.K. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J. Immunol. 153:1994;4766-4774.
2. Bacha P., Forte S.E., Perper S.J., Trentham D.E., Nichols J.C. Anti-arthritic effects demonstrated by an interleukin-2 receptor-targeted cytotoxin (DAB486IL-2) in rat adjuvant arthritis. Eur. J. Immunol. 22:1992;1673-1679.
3. Choy E.H., Hazleman B., Smith M., Moss K., Lisi L., Scott D.G., Patel J., Sopwith M., Isenberg D.A. Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis. a phase II double-blinded, randomized, dose-escalating trial Rheumatology (Oxford). 41:2002;1133-1137.
4. Feldmann M., Brennan F.M., Maini N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:1996;397-440.
5. Feldmann M., Elliott M.J., Woody J.N., Maini R.N. Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis. Adv. Immunol. 64:1997;283-350.
6. Finotto S., Neurath M.F., Glickman J.N., Qin S., Lehr H.A., Green F.H., Ackerman K., Haley K., Galle P.R., Szabo S.J., et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science. 295:2002;336-338.
7. Forsthuber T., Yip H.C., Lehmann P.V. Induction of TH1 and TH2 immunity in neonatal mice. Science. 271:1996;1728-1730.
8. Gammon G., Don K., Shastri N., Oki A., Wilbur S., Sercarz E.E. Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation. Nature. 309:1986;413-415.
9. Garren H., Ruiz P.J., Watkins T.A., Fontoura P., Nguyen L.T., Estline E.R., Hirschberg D.L., Steinman L. Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway. Immunity. 15:2001;15-22.
10. Gong J.H., Ratkay L.G., Waterfield J.D., Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J. Exp. Med. 186:1997;131-137.
11. Grabie N., Karin N. Expansion of neonatal tolerance to self in adult life. II. Tolerance preferentially spreads in an intramolecular manner Int. Immunol. 11:1999;907-913.
12. Grabie N., Wohl I., Youssef S., Wildbaum G., Karin N. Expansion of neonatal tolerance to self in adult life. I. The role of a bacterial adjuvant in tolerance spread Int. Immunol. 11:1999;899-906.
13. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737-742.
14. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by Coxsackie virus. initiation by bystander damage and not molecular mimicry Nat. Med. 4:1998;781-785.
15. Huang D., Han Y., Rani M.R., Glabinski A., Trebst C., Sorensen T., Tani M., Wang J., Chien P., O'Bryan S., et al. Chemokines and chemokine receptors in inflammation of the nervous system. manifold roles and exquisite regulation Immunol. Rev. 177:2000;52-67.
16. Izikson L., Klein R.S., Charo I.F., Weiner H.L., Luster A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192:2000;1075-1080.
17. Karpus W.J., Lukacs N.W., McRae B.L., Strieter R.M., Kunkel S.L., Miller S.D. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:1995;5003-5010.
18. Krakowski M., Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1996;1641-1646.
19. Mor G., Yamshchikov G., Sedegah M., Takeno M., Wang R., Houghten R.A., Hoffman S., Klinman D.M. Induction of neonatal tolerance by plasmid DNA vaccination of mice. J. Clin. Invest. 98:1996;2700-2705.
20. Pearson C.M. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc. Soc. Exp. Biol. Med. 91:1956;95-101.
21. Raz E., Tighe H., Sato Y., Corr M., Dudler J.A., Roman M., Swain S.L., Spiegelberg H.L., Carson D.A. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA. 93:1996;5141-5145.
22. Ridge J.P., Fuchs E.J., Matzinger P. Neonatal tolerance revisited. turning on newborn T cells with dendritic cells Science. 271:1996;1723-1726.
23. Salomon I., Netzer N., Wildbaum G., Schif-Zuck S., Maor G., Karin N. Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis. J. Immunol. 169:2002;2685-2693.
24. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessery for effective intradermal gene immunization. Science. 273:1996;352-357.
25. Singh R.R., Hahn B.H., Sercarz E.E. Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation. implications for antibody vs. T cell-mediated autoimmunity J. Exp. Med. 183:1996;1613-1621.
26. Steinman L. Escape from "horror autotoxicus" pathogenesis and treatment of autoimmune disease Cell. 80:1995;7-10.
27. Suvannavejh G.C., Dal Canto M.C., Matis L.A., Miller S.D. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 105:2000;223-231.
28. Underhill D.M., Ozinsky A. Phagocytosis of microbes. complexity in action Annu. Rev. Immunol. 20:2002;825-852.
29. Vanderlugt C.L., Miller S.D. Epitope spreading in immune-mediated diseases. implications for immunotherapy Nat. Rev. Immunol. 2:2002;85-95.
30. Wallach D. Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J. Immunol. 132:1984;2464-2469.
31. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., Linington C. Animal models. Ann. Neurol. 36:1994;S47-S53.
32. Wen-Ming C., Xing Gong K., Zhi-Wei L., Takabayash K., Hong-Hai O., Chen Y., Lois A., Chen D.J., Li C.G., Karin M., Raz E. DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell. 103:2000;909-918.
33. Wildbaum G., Youssef S., Grabie N., Karin N. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. J. Immunol. 161:1998;6368-6374.
34. Wildbaum G., Karin N. Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-alpha) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis. Gene Ther. 6:1999;1128-1138.
35. Wildbaum G., Westermann J., Maor G., Karin N. A targeted DNA vaccine encoding fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis. J. Clin. Invest. 106:2000;671-679. a.
36. Wildbaum G., Youssef S., Karin N. A targeted DNA vaccine augments the natural immune response to self TNF-alpha and suppresses ongoing adjuvant arthritis. J. Immunol. 165:2000;5860-5866. b.
37. Wildbaum G., Netzer N., Karin N. Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J. Clin. Invest. 110:2002;701-710. b.
38. Wildbaum G., Netzer N., Karin N. Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. J. Immunol. 168:2002;5885-5892. a.
39. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity. viral peptides activate human T cell clones specific for myelin basic protein Cell. 80:1995;695-705.
40. Youssef S., Wildbaum G., Maor G., Lanir N., Gour-Lavie A., Grabie N., Karin N. Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines. J. Immunol. 161:1998;3870-3879.
41. Youssef S., Maor G., Wildbaum G., Grabie N., Gour-Lavie A., Karin N. C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. J. Clin. Invest. 106:2000;361-371.